Advantages of bertimide vs. lintalitamide and the efficacy of transplant for high-risk patients

This chapter discusses the potential benefits and drawbacks of using bertimide and lintalitamide as second primary treatments. It also debates the effectiveness of transplant for high-risk patients, analyzing the progression-free survival advantage in standard risk patients and considering the impact of age and frailty in the study.